Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$82 Mln
P/E Ratio
--
P/B Ratio
0.48
Industry P/E
--
Debt to Equity
0.01
ROE
-0.38 %
ROCE
-30.74 %
Div. Yield
0 %
Book Value
24.21
EPS
-10.59
CFO
$-419.24 Mln
EBITDA
$-479.39 Mln
Net Profit
$-580.25 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Tanker Investments (TIL)
| -38.61 | -35.18 | -54.24 | 10.57 | -57.53 | -- | -- |
|
BSE Sensex*
| 2.79 | 3.89 | 4.78 | 7.71 | 12.12 | 19.71 | 11.44 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
|
|---|---|---|---|
|
Tanker Investments (TIL)
| 148.66 | -39.52 | -96.32 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 38.55 | 10,593.45 | 21.84 | 23.13 | |
| 306.35 | 8,570.17 | 22.78 | 66.44 | |
| 27.82 | 10,589.59 | -- | -28.77 | |
| 107.24 | 10,559.67 | 32.44 | 14.16 |
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in... patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors, including triple-negative breast cancer, squamous non-small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors, such as soft tissue sarcomas and thymic cancer. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas. Address: 3963 Maple Avenue, Dallas, TX, United States, 75219 Read more
Chairman & CEO
Mr. Bronson Crouch
Chairman & CEO
Mr. Bronson Crouch
Headquarters
Dallas, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Tanker Investments Ltd (TIL) stood at $ 264 Mln as on 31-Dec-24
The share price of Tanker Investments Ltd (TIL) is $11.72 (NASDAQ) as of 29-Apr-2025 16:00 EDT. Tanker Investments Ltd (TIL) has given a return of -57.53% in the last 3 years.
Tanker Investments Ltd (TIL) has a market capitalisation of $ 82 Mln as on 29-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Tanker Investments Ltd (TIL) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Tanker Investments Ltd (TIL) and enter the required number of quantities and click on buy to purchase the shares of Tanker Investments Ltd (TIL).
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors, including triple-negative breast cancer, squamous non-small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors, such as soft tissue sarcomas and thymic cancer. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas. Address: 3963 Maple Avenue, Dallas, TX, United States, 75219
The CEO & director of Mr. Bronson Crouch. is Tanker Investments Ltd (TIL), and CFO & Sr. VP is Mr. Bronson Crouch.
There is no promoter pledging in Tanker Investments Ltd (TIL).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,014
|
|
|
1,003
|
|
|
956
|
|
|
867
|
| Tanker Investments Ltd (TIL) | Ratios |
|---|---|
|
Return on equity(%)
|
-37.51
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Tanker Investments Ltd (TIL) was $0 Mln.
$-0.72
(
